Technical Analysis for XNCR - Xencor, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| See historical XNCR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Mar 22 | Fell Below 20 DMA | Bearish | 0.00% |
| Mar 22 | Bollinger Band Squeeze | Range Contraction | 0.00% |
| Mar 22 | Multiple of Ten Bearish | Other | 0.00% |
| Mar 21 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -6.73% |
| Mar 21 | Bollinger Band Squeeze | Range Contraction | -6.73% |
| Mar 21 | Calm After Storm | Range Contraction | -6.73% |
| Mar 21 | BB Squeeze + Upper Band Touch | Range Contraction | -6.73% |
| Mar 21 | Inside Day | Range Contraction | -6.73% |
| Mar 21 | Upper Bollinger Band Touch | Strength | -6.73% |
| Mar 20 | 50 DMA Resistance | Bearish | -7.36% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2019-02-25
- Sector: Healthcare
- Industry: Bio Therapeutic Drugs
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases. It develops its antibody product candidates to treat autoimmune and allergic diseases, cancer, and other conditions through XmAb technology platform. The company's engineered antibodies that are in development include XmAb5871, a B-cell inhibitor that is in Phase Ib/IIa clinical trials for the treatment of autoimmune diseases, such as rheumatoid arthritis and lupus; XmAb7195, an IgE inhibitor to treat severe asthma and allergic diseases; and XmAb5574/MOR208, a Cytotoxic B-cell depleting product candidate for the treatment of B-cell cancers. It has a collaboration agreement with Boehringer Ingelheim International GmbH; and development and manufacturing services agreement with Catalent Pharma Solutions LLC. The company was founded in 1997 and is based in Monrovia, California.
Medicine Biotechnology Biopharmaceutical Cancer Medical Specialties Life Sciences Immunology Antibodies Immune System Monoclonal Antibodies Autoimmune Diseases Rheumatoid Arthritis Antibody Glycoproteins Treatment Of Autoimmune Diseases Lupus Boehringer Ingelheim Immunoglobulin E Manufacturing Services Agreement
Medicine Biotechnology Biopharmaceutical Cancer Medical Specialties Life Sciences Immunology Antibodies Immune System Monoclonal Antibodies Autoimmune Diseases Rheumatoid Arthritis Antibody Glycoproteins Treatment Of Autoimmune Diseases Lupus Boehringer Ingelheim Immunoglobulin E Manufacturing Services Agreement
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more XNCR news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 48.38 |
| 52 Week Low | 27.57 |
| Average Volume | 240,226 |
| 200-Day Moving Average | 37.3671 |
| 50-Day Moving Average | 33.016 |
| 20-Day Moving Average | 30.3335 |
| 10-Day Moving Average | 30.133 |
| Average True Range | 1.7762 |
| ADX | 27.0 |
| +DI | 26.283 |
| -DI | 23.8763 |
| Chandelier Exit (Long, 3 ATRs ) | 29.9614 |
| Chandelier Exit (Short, 3 ATRs ) | 33.0786 |
| Upper Bollinger Band | 32.6145 |
| Lower Bollinger Band | 28.0525 |
| Percent B (%b) | 0.41 |
| BandWidth | 15.039478 |
| MACD Line | -0.7345 |
| MACD Signal Line | -1.0687 |
| MACD Histogram | 0.3343 |
| Fundamentals | Value |
|---|---|
| Market Cap | 1.4 Billion |
| Num Shares | 46.9 Million |
| EPS | -0.87 |
| Price-to-Earnings (P/E) Ratio | -34.41 |
| Price-to-Sales | 29.06 |
| Price-to-Book | 3.08 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 32.84 | ||||
| Resistance 3 (R3) | 33.15 | 32.51 | 32.35 | ||
| Resistance 2 (R2) | 32.51 | 31.77 | 32.35 | 32.19 | |
| Resistance 1 (R1) | 31.22 | 31.31 | 30.90 | 30.91 | 32.03 |
| Pivot Point | 30.58 | 30.58 | 30.42 | 30.42 | 30.58 |
| Support 1 (S1) | 29.29 | 29.84 | 28.97 | 28.98 | 27.85 |
| Support 2 (S2) | 28.65 | 29.38 | 28.49 | 27.69 | |
| Support 3 (S3) | 27.36 | 28.65 | 27.53 | ||
| Support 4 (S4) | 27.05 |
